Vimarsana
Biggest News Aggregation in the World

Page 37 - Lockup News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lockup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lockup Today - Breaking & Trending Today

Taylor Swift Brought Back Some Original 'Love Story' Musicians for the Remake: Who Returned and Who Didn't - Vimarsana News

Taylor Swift Brought Back Some Original 'Love Story' Musicians for the Remake: Who Returned and Who Didn't

Skip to main content Currently Reading Taylor Swift Brought Back Some Original 'Love Story' Musicians for the Remake: Who Returned and Who Didn't Chris Willman, provided by FacebookTwitterEmail Now that credits have been made available, it’s evident that Swift is using some of the O.G. players, when possible, instead of trying to get the same sounds with ringers. Although it remains to foretell what the future holds as Swift makes her way through her entire six-album Big Machine catalog, it’s interesting to see several names familiar to credit-scanners from 2008 show up in 2021. More fr...

Republic Records Promotes Gary Spangler to Executive Vice President - Vimarsana News

Republic Records Promotes Gary Spangler to Executive Vice President

Republic Records Promotes Gary Spangler to Executive Vice President Variety Staff, provided by FacebookTwitterEmail Gary Spangler has been promoted to executive vice president of Republic Records, label founder and CEO Monte Lipman announced. In this role,  Spangler will continue to shepherd promotion for acts on the Republic and Island Records rosters, according to the announcement. A 14-year veteran of the company and executive VP of promotion since 2016, he has orchestrated and executed promotion campaigns for the likes of Ariana Grande, Drake, Jonas Brothers, Nicki Minaj, Post...

Cops conducting thorough investigation into custodial death in Yan - Vimarsana News

Cops conducting thorough investigation into custodial death in Yan

ALOR SETAR (Bernama): Police are conducting a thorough investigation into the death of a detainee in the lockup of Yan Police headquarters on Jan 28. Kedah Police chief Datuk Hasanuddin Hassan said the investigation was to determine whether there were elements of violence, negligence or misconduct by police personnel as well as possibility of injury during the arrest. "To date, a total of 47 witnesses have had their statements taken. They are family members as well as police personnel involved in the arrest and the ones manning the lockup. "Others are the detainees who were in same the lockup...

Gillian Anderson Gets Teary-Eyed Over 'The Crown' Golden Globes Nod: 'I Put My Heart and Soul Into the Role' - Vimarsana News

Gillian Anderson Gets Teary-Eyed Over 'The Crown' Golden Globes Nod: 'I Put My Heart and Soul Into the Role'

Skip to main content Currently Reading Gillian Anderson Gets Teary-Eyed Over 'The Crown' Golden Globes Nod: 'I Put My Heart and Soul Into the Role' Mónica Marie Zorrilla, provided by Feb. 3, 2021 FacebookTwitterEmail It isn’t often that  Variety gets to break news to “The Crown” star and seasoned award-winning actor Gillian Anderson, but on the afternoon of Feb. 3, Anderson found herself rushing through the door after a photoshoot to get on the phone with us. She had no idea that what she had missed in the midst of getting through her to-do list was groundbreaking. “Three?!?! What...

IPO Lockup Expiration Alert: ITeos Therapeutics (ITOS) - Vimarsana News

IPO Lockup Expiration Alert: ITeos Therapeutics (ITOS)

IPO Lockup Expiration Alert: ITeos Therapeutics (ITOS) iTeos Therapeutics is a clinical-stage biopharmaceutical company developing immuno-oncology therapeutics. The company's lead drug candidates - EOS-850 and EOS-448 - are in phase 1/2a clinical trials in adult patients with advanced solid tumors and in multiple advanced solid tumors, respectively. The initial single-agent and combination data from the phase 1/2a clinical trials of EOS-850 are expected in the first half of 2021. The initial safety and efficacy data from phase I/IIa clinical trial of EOS-448 as a monotherapy for patients with...